Skip to main content
Elsevier

Annual Reports in Medicinal Chemistry: Roadmaps

  • 1st Edition, Volume 62 - October 30, 2024
  • Latest edition
  • Editor: Katherine Seley-Radtke
  • Language: English

Annual Reports in Medicinal Chemistry: Roadmaps, Volume 62 highlights new advances in the field, with this new volume presenting interesting chapters written by an internati… Read more

Description

Annual Reports in Medicinal Chemistry: Roadmaps, Volume 62 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. This release provides a compendium of information on newly approved drugs and compounds entering late-stage clinical trials, making it a valuable resource for graduate students pursuing research in medicinal chemistry

Key features

  • Reviews on hot topics of interest in small molecule drug discovery heavily pursued by industrial research organizations
  • Provides preclinical information in the context of chemical structures
  • Includes section editors who are highly knowledgeable and who can evaluate invited reviews for scientific rigor

Readership

Ideally suited for chemists engaged in multidisciplinary teams for drug discovery including medicinal chemists and others involved in chemical biology and bio-organic disciplines and computational chemistry

Table of contents

1. Roadmap chapter on Antiparasitic natural products
Fyaz Ismail

2. Roadmap chapter on The hybrid antimalarial approach
Kamaljit Singh

3. Roadmap chapter on Antidiabetic natural products
Pulok K. Mukherjee

Product details

  • Edition: 1
  • Latest edition
  • Volume: 62
  • Published: November 5, 2024
  • Language: English

About the editor

KS

Katherine Seley-Radtke

Prof. Katherine Seley-Radtke group’s NIH-funded research employs a chemical biology approach to nucleoside, nucleotide and heterocyclic drug discovery and development with therapeutic emphasis on antiviral, anticancer and antiparasitic targets and overcoming resistance to currently used drugs. Current focus is targeting Ebola, Zika, Dengue and MERS viruses. She has served as the Program Director for UMBC’s Chemistry-Biology Interface graduate training program funded by NIH since 2007. This program promotes hands on cross disciplinary research for almost 50 PhD students from four departments at UMBC and UMB. She is currently the Immediate Past President and Secretary-Elect for the International Society of Nucleosides, Nucleotides and Nucleic Acids and a Board member of the International Society for Antiviral Research. Prof. Seley-Radtke also serves as a standing member for several NIH study sections and is an Associate Editor for three scientific journals – Antiviral Chemistry & Chemotherapy, Molecules – Chemical Biology, and Current Protocols in Chemical Biology.
Affiliations and expertise
Professor of Chemistry and Biochemistry, University of Maryland, Baltimore County, MD, USA

View book on ScienceDirect

Read Annual Reports in Medicinal Chemistry: Roadmaps on ScienceDirect